RO 17-2301 - INVITRO COMPARISON WITH AZTREONAM, IMIPENEM, CEFTAZIDIME, CEFOTAXIME AND NETILMICIN

被引：8

作者：

DIGRANES, A ^{[1
]}

DIBB, WL ^{[1
]}

BENONISEN, E ^{[1
]}

SALVESON, A ^{[1
]}

机构：

[1] F HOFFMANN LA ROCHE & CO LTD,DEPT CLIN RES,OSLO,NORWAY

来源：

关键词：

D O I：

10.1159/000238348

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：279 / 285

页数：7

共 14 条

[1] ANGEHRN P, 13TH INT C CHEM VIEN
[2] ARISAWA M, 1983, 23RD INT C ANT AG CH
[3] CLOSS O, 1971, ACTA PATHOLOG MICROB, VB 79, P673
[4] Cowan S. T., 1975, MANUAL IDENTIFICATIO
[5] PSEUDOMONAS-AERUGINOSA AND ACINETOBACTER-CALCOACETICUS - INVITRO SUSCEPTIBILITY OF 150 CLINICAL ISOLATES TO 5 BETA-LACTAM ANTIBIOTICS AND TOBRAMYCIN
DIBB, WL
KJELLEVOLD, VA
DIGRANES, A
[J]. CHEMOTHERAPY, 1983, 29 (05) : 332 - 336
[6] DIGRANES A, 1983, ACTA PATH MICRO IM B, V91, P141
[7] Ericsson H.M., 1971, ACTA PATHOL MICR B S, P217
[8] INVITRO ACTIVITY OF AZTHREONAM, A MONOBACTAM ANTIBIOTIC
JACOBUS, NV
FERREIRA, MC
BARZA, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) : 832 - 838
[9] KONDO M, 1983, 13TH INT C CHEM VIEN
[10] INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF A MONOBACTAM, SQ 26,917, COMPARED WITH THOSE OF AZTREONAM AND OTHER AGENTS
NEU, HC
LABTHAVIKUL, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) : 227 - 232